NeuroSense Therapeutics
achieved primary with a safety and tolerability profile comparable to placebo phase study results | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
January 2024
Slide
16 of 33
Similar slides by NeuroSense Therapeutics
See diffirences between slides (animation)
Investor Presentation
December 2023
phase study results achieved primary with a safety and tolerability profile comparable to placebo | NeuroSense Therapeutics
Related slides by other companies
Aeglea BioTherapeutics
Investor Presentation
May 2023
interim results from phase clinical trial safety summary | Aeglea BioTherapeutics
Aeglea BioTherapeutics
Investor Presentation
April 2023
interim results from phase clinical trial safety summary | Aeglea BioTherapeutics
MindMed
Results
May 2022
phase study results key phase study results support progression of into planned upcoming phase clinical program well tolerated up to per day in single ascending dose sad and per day in the multiple ascending dose mad linear maintained across the tested doses and frequencies clinical effects align with potent engagement regimen aligns with preclinical evidence offers potential to be a more effective regimen in withdrawal | MindMed
MindMed
Investor Presentation
June 2023
phase study results key phase study results support progression of results from phase progression of clinical trial demonstrate tolerability and support linear maintained across the tested doses and clinical effects align with potent regimen suitable regimen in withdrawal aligns with preclinical evidence offers potential to be a more frequencies engagement | MindMed
Other recent decks by NeuroSense Therapeutics
See all presentations (3 decks)
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io